ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn't work well for some tumors, ...

A vaccine that tackles the bacteria that cause up to 200 million childhood infections every year could be possible, experts ...

Research shows life expectancy growth is slowing, with significant implications for health policies and individual planning ...

On World Cities Day, the World Health Organization (WHO) calls on national and city leaders to transform urban areas into ...

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, ...

MAGA and MAHA are happily married in Florida, and nowhere more at home than in Sarasota County, where on a humid October ...

Research shows that powdered infant formula may contain microbial contaminants despite following 70°C preparation guidelines, ...

A massive cross-ancestry genetic study involving over 839,000 adults identified 13 genes linked to obesity, including five ...

Children born to mothers who contracted COVID-19 during pregnancy face a 29% higher likelihood of developmental disorders by ...

In the largest synthesis to date, researchers reviewed 155 studies linking viral infections, including influenza, SARS-CoV-2, ...

A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative ...